Darren Robertson

1.6k total citations
25 papers, 1.2k citations indexed

About

Darren Robertson is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology and Pharmacology. According to data from OpenAlex, Darren Robertson has authored 25 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Physiology and 7 papers in Pharmacology. Recurrent topics in Darren Robertson's work include Diabetes Treatment and Management (14 papers), Pharmacology and Obesity Treatment (6 papers) and Metabolism, Diabetes, and Cancer (6 papers). Darren Robertson is often cited by papers focused on Diabetes Treatment and Management (14 papers), Pharmacology and Obesity Treatment (6 papers) and Metabolism, Diabetes, and Cancer (6 papers). Darren Robertson collaborates with scholars based in United Kingdom, United States and Sweden. Darren Robertson's co-authors include Susan M. Fleetwood-Walker, Heather A. Anderson, Rory Mitchell, Emer M. Garry, Roberta Rosie, David F. Cottrell, Phil Ambery, Marcella Petrone, Lutz Jermutus and Boaz Hirshberg and has published in prestigious journals such as The Lancet, Gastroenterology and Molecular and Cellular Biology.

In The Last Decade

Darren Robertson

24 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Darren Robertson United Kingdom	14	397	361	279	276	236	25	1.2k
Rita Benkő Hungary	18	251 0.6×	195 0.5×	107 0.4×	289 1.0×	118 0.5×	67	1.2k
Michele L. Nealen United States	11	152 0.4×	415 1.1×	237 0.8×	250 0.9×	772 3.3×	12	1.6k
Susanne K. Sauer Germany	26	52 0.1×	823 2.3×	445 1.6×	504 1.8×	543 2.3×	46	1.8k
Stacey Barrick United States	16	53 0.1×	303 0.8×	170 0.6×	421 1.5×	524 2.2×	21	1.7k
Mallappa Anitha United States	18	119 0.3×	417 1.2×	208 0.7×	684 2.5×	24 0.1×	36	1.8k
Heike Benecke Germany	20	317 0.8×	274 0.8×	93 0.3×	638 2.3×	235 1.0×	31	1.4k
K. C. Dines United Kingdom	20	175 0.4×	828 2.3×	162 0.6×	187 0.7×	33 0.1×	32	1.4k
Adam I. Cygankiewicz Poland	20	109 0.3×	339 0.9×	158 0.6×	323 1.2×	90 0.4×	29	1.2k
Krisztián Elekes Hungary	22	49 0.1×	607 1.7×	488 1.7×	311 1.1×	551 2.3×	27	1.3k
Gábor Pozsgai Hungary	20	48 0.1×	377 1.0×	407 1.5×	233 0.8×	476 2.0×	37	1.2k

Countries citing papers authored by Darren Robertson

Since Specialization

Citations

This map shows the geographic impact of Darren Robertson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Darren Robertson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Darren Robertson more than expected).

Fields of papers citing papers by Darren Robertson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Darren Robertson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Darren Robertson. The network helps show where Darren Robertson may publish in the future.

Co-authorship network of co-authors of Darren Robertson

This figure shows the co-authorship network connecting the top 25 collaborators of Darren Robertson. A scholar is included among the top collaborators of Darren Robertson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Darren Robertson. Darren Robertson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Parker, Victoria, Lars Hansen, Darren Robertson, et al.. (2025). Pharmacokinetic‐pharmacodynamic (PK/PD) modelling of cotadutide effect in patients with chronic kidney disease and type 2 diabetes mellitus. British Journal of Clinical Pharmacology. 91(9). 2672–2683.

Ueckert, Sebastian, Lina Zhou, Jenny Cheng, et al.. (2024). Exposure–response modeling for nausea incidence for cotadutide using a Markov modeling approach. CPT Pharmacometrics & Systems Pharmacology. 13(9). 1582–1594. 2 indexed citations

Shankar, Sudha S., Samuel J. Daniels, Darren Robertson, et al.. (2024). Safety and Efficacy of Novel Incretin Co-agonist Cotadutide in Biopsy-proven Noncirrhotic MASH With Fibrosis. Clinical Gastroenterology and Hepatology. 22(9). 1847–1857.e11. 21 indexed citations

Golubić, Rajna, Jane Kennet, Victoria Parker, et al.. (2024). Dual glucagon‐like peptide ‐1 and glucagon receptor agonism reduces energy intake in type 2 diabetes with obesity. Diabetes Obesity and Metabolism. 26(7). 2634–2644. 9 indexed citations

Parker, Victoria, Darren Robertson, Bas Havekes, et al.. (2023). Cotadutide promotes glycogenolysis in people with overweight or obesity diagnosed with type 2 diabetes. Nature Metabolism. 5(12). 2086–2093. 35 indexed citations

Asano, Michiko, et al.. (2023). Safety/tolerability, efficacy and pharmacokinetics of 600‐μg cotadutide in Japanese type 2 diabetes patients with a body mass index of 25 kg/m ² or higher: A phase I, randomized, double‐blind, placebo‐controlled study. Diabetes Obesity and Metabolism. 25(8). 2290–2299. 9 indexed citations

Robertson, Darren, Lars Hansen, Lutz Jermutus, et al.. (2023). #3000 EFFICACY AND SAFETY OF COTADUTIDE, A DUAL GLP1-GLUCAGON RECEPTOR AGONIST, IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND T2DM. Nephrology Dialysis Transplantation. 38(Supplement_1). 1 indexed citations

Robertson, Darren, Lars Hansen, Phil Ambery, et al.. (2020). 354-OR: Cotadutide (medi0382), a Dual Receptor Agonist with Glucagon-Like Peptide-1 and Glucagon Activity, Modulates Hepatic Glycogen and Fat Content. Diabetes. 69(Supplement_1). 5 indexed citations

Parker, Victoria E R, Darren Robertson, Tao Wang, et al.. (2019). 1017-P: Continuous Glucose Monitoring Reveals Comprehensive Glucose Control with MEDI0382, an Oxyntomodulin-Like Peptide with Targeted GLP-1/Glucagon Receptor Activity. Diabetes. 68(Supplement_1). 1 indexed citations

10.

Robertson, Darren, Victoria E R Parker, Phil Ambery, et al.. (2019). 988-P: MEDI0382, an Oxyntomodulin-Like Peptide with Targeted GLP-1/Glucagon Receptor Activity, Promotes a Dose-Dependent Increase in Gastric Emptying Time. Diabetes. 68(Supplement_1). 3 indexed citations

11.

Jain, Meena, Darren Robertson, Boaz Hirshberg, et al.. (2018). MEDI0382, a GLP/Glucagon Receptor Dual Agonist, Significantly Reduces Hepatic Fat Content in Subjects with Type 2 Diabetes Mellitus. Diabetes. 67(Supplement_1). 8 indexed citations

12.

Ambery, Phil, Victoria E R Parker, Michael Stümvoll, et al.. (2018). MEDI0382, a GLP-1 and glucagon receptor dual agonist, in obese or overweight patients with type 2 diabetes: a randomised, controlled, double-blind, ascending dose and phase 2a study. The Lancet. 391(10140). 2607–2618. 243 indexed citations

13.

Hobson, Ruth M., Adam D. Farmer, Odile Dewit, et al.. (2015). The effects of camicinal, a novel motilin agonist, on gastro‐esophageal function in healthy humans—a randomized placebo controlled trial. Neurogastroenterology & Motility. 27(11). 1629–1637. 15 indexed citations

14.

Barton, Matthew E., Darren Robertson, Robert L. Dobbins, et al.. (2014). 70 A Randomized, Double-Blind, Placebo-Controlled Phase II Study (MOT114479) to Evaluate the Safety and Efficacy and Dose Response of 28 Days of Orally Administered Camicinal, a Motilin Receptor Agonist, in Diabetics With Gastroparesis. Gastroenterology. 146(5). S–20. 27 indexed citations

15.

Beaumont, Claire, Steve Thomas, Darren Robertson, et al.. (2011). Use of Entero‐Test, a simple approach for non‐invasive clinical evaluation of the biliary disposition of drugs. British Journal of Clinical Pharmacology. 72(1). 133–142. 23 indexed citations

16.

Jones, Emma, Ada Delaney, Heather A. Anderson, et al.. (2007). Neuropathic changes in equine laminitis pain. Pain. 132(3). 321–331. 76 indexed citations

17.

Garry, Emer M., David F. Cottrell, Roberta Rosie, et al.. (2006). Analgesia Mediated by the TRPM8 Cold Receptor in Chronic Neuropathic Pain. Current Biology. 16(16). 1591–1605. 326 indexed citations

18.

Garry, Emer M., Ada Delaney, Gordon Blackburn-Munro, et al.. (2005). Activation of p38 and p42/44 MAP kinase in neuropathic pain: Involvement of VPAC2 and NK2 receptors and mediation by spinal glia. Molecular and Cellular Neuroscience. 30(4). 523–537. 40 indexed citations

19.

Robertson, Darren, Oliver Schmidt, Natalia Ninkina, et al.. (2004). Developmental loss and resistance to MPTP toxicity of dopaminergic neurones in substantia nigra pars compacta of γ‐synuclein, α‐synuclein and double α/γ‐synuclein null mutant mice. Journal of Neurochemistry. 89(5). 1126–1136. 120 indexed citations

20.

Ninkina, Natalia, Katerina K. Papachroni, Darren Robertson, et al.. (2003). Neurons Expressing the Highest Levels of γ-Synuclein Are Unaffected by Targeted Inactivation of the Gene. Molecular and Cellular Biology. 23(22). 8233–8245. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact